Steroids in late ARDS?

1.

Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006, 354: 1671-1684. 10.1056/NEJMoa051693CrossRefPubMed

2.

Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, Kariman K, Higgins S, Bradley R, Metz CA: High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987, 317: 1565-1570.CrossRefPubMed

3.

Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF: Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988, 138: 62-68.CrossRefPubMed

4.

Annane D, Sebille V, Bellissant E, Ger-Inf-05 Study Group: Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006, 34: 22-30. 10.1097/01.CCM.0000194723.78632.62CrossRefPubMed

5.

Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R: Methylprednisolone Infusion in Early Severe ARDS*Results of a Randomized Controlled Trial. Chest 2007, 131: 954-963. 10.1378/chest.06-2100CrossRefPubMed

6.

Biffl WL, Moore FA, Moore EE, Haenel JB, McIntyre RC Jr, Burch JM: Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome? Am J Surg 1995, 170: 591-595. 10.1016/S0002-9610(99)80022-1CrossRefPubMed

7.

Keel JB, Hauser M, Stocker R, Baumann PC, Speich R: Established acute respiratory distress syndrome: benefit of corticosteroid rescue therapy. Respiration 1998, 65: 258-264. 10.1159/000029273CrossRefPubMed

8.

Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA: Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280: 159-165. 10.1001/jama.280.2.159CrossRefPubMed

9.

Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H: Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003, 167: 512-520. 10.1164/rccm.200205-446OCCrossRefPubMed

10.

Keel JB, Hauser M, Stocker R, Baumann PC, Speich R: Established acute respiratory distress syndrome: benefit of corticosteroid rescue therapy. Respiration 1998, 65: 258-264. 10.1159/000029273CrossRefPubMed

11.

Lew KH, Ludwig EA, Milad MA, Donovan K, Middleton E Jr, Ferry JJ, Jusko WJ: Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1993, 54: 402-414.PubMedCentralCrossRefPubMed

12.

Fleming TR, DeMets DL: Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996, 125: 605-613.CrossRefPubMed

13.

Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999, 341: 785-792. 10.1056/NEJM199909093411102CrossRefPubMed

14.

Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML: Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991, 325: 1468-1475.CrossRefPubMed

15.

DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R: A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989, 320: 677-683.CrossRefPubMed

16.

Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. The Cardiac Arrhythmia Pilot Study (CAPS) Investigators Am J Cardiol 1988, 61: 501-509. 10.1016/0002-9149(88)90754-0

17.

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators N Engl J Med 1989, 321: 406-412.

18.

Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340: 409-417. 10.1056/NEJM199902113400601CrossRefPubMed

19.

Griffiths MJ, Evans TW: Inhaled nitric oxide therapy in adults. N Engl J Med 2005, 353: 2683-2695. 10.1056/NEJMra051884CrossRefPubMed

20.

Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W: Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004, 351: 884-892. 10.1056/NEJMoa033181CrossRefPubMed

21.

Marshall JC, Vincent JL, Guyatt G, Angus DC, Abraham E, Bernard G, Bombardier C, Calandra T, Jorgensen HS, Sylvester R, Boers M: Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med 2005, 33: 1708-1716. 10.1097/01.CCM.0000174478.70338.03CrossRefPubMed

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Steroids in late ARDS?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2007

Year in review 2006: Critical Care – multiple organ failure, sepsis, and shock

Year in review 2006: Critical Care – resource management

Caudwell Xtreme Everest: a field study of human adaptation to hypoxia

A survey of Canadian intensivists' resuscitation practices in early septic shock

Pocket Guide to Perioperative and Critical Care Echocardiography

Acute kidney injury in the intensive care unit: current trends in incidence and outcome